Regostenol

Species

Cattle (cows).

Composition

1 ml contains:
- Active substance: Sodium D-cloprostenol - 0.263 mg (equivalent to 0.250 mg of D-cloprostenol)
- Excipients: Dihydrogen phosphate of potassium, sodium hydroxide, chlorocresol, and water for injections.

Indications

Indicated for cows and heifers for the regulation of reproductive function, synchronization of the estrous cycle, treatment of gynecological diseases, induction of estrus, treatment of functional ovarian disorders (luteal cyst, persistent corpus luteum), treatment of follicular cysts (in combination with chorionic gonadotropin, according to the leaflet), prevention and treatment of postpartum pathologies, as well as termination of pathological gestation.

Dosage and method of administration

Regostenol is administered intramuscularly at a dose of 1-2 ml per animal. The dosage for each specific case will be determined by the veterinarian based on the medical history, the specifics of the pathological process, or according to the timing of the therapeutic effect.

Indications	Method of administration
Induction and synchronization of estrus.	It is administered at any time during the cycle, with subsequent insemination occurring upon the manifestation of estrus. Animals in anestrus are injected repeatedly for 11 days. If insemination occurs without the onset of estrus symptoms, it should be performed 72 and 96 hours after the repeated administration.
Treatment of ovarian dysfunctions (luteal cyst, persistent corpus luteum).	Administered after diagnosis is established, with subsequent insemination upon the manifestation of estrus.
Treatment of follicular cysts.	After establishing the diagnosis, chorionic gonadotropin is administered, followed by Regostenol after 11 days.
Prophylaxis and treatment of postpartum pathologies (retained placenta, endometritis, pyometra).	It is administered alongside etiological, pathogenetic, and symptomatic therapy. In the case of chronic endometritis, repeated administration every 10-14 days is permitted.
Stimulation of parturition and prevention of retained placenta.	It is administered on the day of delivery in cases of weak contractions, except in cases of large fetal volume and abnormal positions or presentations.
Interruption of pathological pregnancy.	Regostenol is administered from the first week up to the fifth month of pregnancy; abortion occurs 2-7 days after administration.

It is recommended to adhere to the administration terms and doses to maintain the effectiveness of the preparation. In case of a missed dose, the schedule should be adjusted based on the physiological condition of the animal. Do not use Regostenol if you observe visible signs of deterioration.

Contraindications

Do not use in animals with increased sensitivity to the components of the medication, during pregnancy, except in cases of terminating pathological pregnancies or inducing parturition. Administration is prohibited in animals with gastrointestinal or respiratory diseases accompanied by spasmodic components.

Waiting period

Meat - 48 hours

Milk - 0 days.

Release form

Glass vials of 20, 50, and 100 ml, with rubber stoppers and secure aluminum caps. Not all packaging sizes may be available for sale.

Storage conditions

Store in a dark place, separate from food and feed, at T°C 5°C + 25°C, in places inaccessible to children.

Shelf life

2 years from the date of production, from the first opening – 28 days.

Do not use after the expiry date indicated on the packaging.

Regostenol

The message was sent successfully!